GeneCentric to Present Data on the Purity Independent Subtyping of Tumor (PurIST℠) Test at AACR Panc
DURHAM, N.C.--(BUSINESS WIRE)--#GeneCentric--GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the poster presentation of further clinical validation data for PurIST℠, a novel RNA-expression test, in collaboration with Tempus. PurIST identifies...
North Carolina United States Stephane Wenric Jamesm Davison National Cancer Institute Genecentric Therapeutics Inc
Source: pharmiweb.com